All Industries

Top Diagnostics Companies

111 Diagnostics companies, sorted by total funding raised.

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth Equity·$1.5B·Apr 2025
Ginkgo BioworksIPO

Our mission is to make biology easier to engineer.

Boston, United States501–1000Automation, Diagnostics
Extension Round·$790.0M·May 2020
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
Convertible·$550.1M·Aug 2025
LetsGet Checked

Providing tools to manage health from home

Dublin, Ireland501–1000Diagnostics, Healthcare
Series F·$448.0M·Jan 2025
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series C·$435.0M·Jun 2021
BillionToOneIPO

The genetic testing platform detecting and measuring disease.

Menlo Park, United States201–500Diagnostics, Genomics
Venture Unknown·$406.0M·Mar 2026
DELFI Diagnostics

Develops blood-based liquid biopsy tests using fragmentomics and machine learning to detect and m...

Baltimore, United States51–200Artificial Intelligence, Biotech
Venture Unknown·$364.8M·Dec 2025
Function Health

Whole body lab and imaging platform for longitudinal biomarker tracking and early detection

Austin, United States201–500Diagnostics, Healthcare
Series B·$354.0M·Nov 2025
NateraIPO

Natera provides DNA testing across multiple clinical areas including women’s health and oncology.

San Carlos, United States5001–10000Diagnostics, Genomics
Series E·$310.1M·Jul 2019
Harrison.ai

Clinician-led company building AI diagnostic and workflow tools for radiology and pathology, serv...

Sydney, Australia201–500Artificial Intelligence, Diagnostics
Series C·$265.3M·Feb 2025
Alamar Biosciences

Precision proteomics company providing automated, ultra-high sensitivity protein analysis platfor...

Fremont51–200Biotech, Diagnostics
Convertible·$258.0M·Jan 2026
Personal Genome DiagnosticsAcquired

Innovative genomic technologies to solve fundamental challenges in oncology

Baltimore, United States51–200Biotech, Cancer Diagnostics
Series C·$244.2M·Feb 2021
Truvian

Develops an automated benchtop blood-testing analyzer that delivers lab-accurate routine blood te...

San Diego, United States51–200Life Sciences, Diagnostics
Growth Equity·$206.1M·Jul 2024
Scipher Medicine

Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...

Boston, United States51–200Artificial Intelligence, Drug Discovery
Series D·$197.8M·Jul 2024
Visby Medical

A device platform that aims to redefine the way we test and treat illness

Tokyo, United States51–200Healthcare, Diagnostics
Venture Unknown·$195.7M·Jun 2025
Cytovale

Medical diagnostics company focused on advancing early detection technologies to diagnose fast-mo...

San Francisco, United States51–200Diagnostics, Healthcare
Series D·$191.4M·Oct 2024
Redcliffe Lifetech

Redcliffe Labs is India's Largest Omni-channel Diagnostics platform

Delhi, India1001–5000Diagnostics, Digital Health
Series C·$151.9M·Sep 2024
Clear Labs

Clear Labs provides food analytics while standardizing molecular food quality the global molecula...

San Francisco, United States51–200Food & Beverage, Genomics
Series D·$150.2M·Dec 2024
SunBird Bio

Develops blood-based protein diagnostics for earlier, more accurate diagnosis and monitoring of A...

Cambridge, United States11–50Biotech, Diagnostics
Series B·$108.2M·Oct 2024
Variantyx

Molecular diagnostics lab providing whole-genome-based genetic testing for rare disorders, reprod...

Boston, United States51–200Diagnostics, Genomics
Series D·$100.0M·Apr 2024
Xilis

Develops MicroOrganoSphere ex vivo tumor models and AI analytics to guide precision oncology and ...

Durham, United States51–200Biotech, Diagnostics
Series A·$92.0M·Apr 2025
QuanterixIPO

Develops ultrasensitive biomarker detection instruments and assays for researchers, pharmaceutica...

Billerica, United States201–500Diagnostics, Healthcare
Series D·$85.5M·Mar 2016
BAEBIES, INC.

R&D company with 44 SBIR/STTR awards from Department of Health and Human Services, Department of ...

DURHAM, United States51–200Biotech, Diagnostics
Series C·$62.6M·Jan 2022
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Series A·$58.5M·Nov 2011
VeracyteIPO

Veracyte is a global cancer diagnostics company that provides genomic tests to help clinicians di...

South San Francisco, United States501–1000Biotech, Diagnostics
Series C·$56.3M·Jun 2013